Navigation Links
New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation
Date:7/6/2009

ear that more research is needed to demonstrate its potential long-term benefits," said AHRQ Director Carolyn M. Clancy, M.D. "This report crystallizes the questions that researchers need to ask going forward."

Atrial fibrillation, the most common type of irregular heartbeat in adults, affects more than 2.2 million Americans, putting them at risk for heart failure, blood clots, or stroke. Patients with atria fibrillation are typically treated with medication first, but medicines only work for about half of patients for preventing recurrence of atrial fibrillation.

The report calls for more research on the effect of radiofrequency catheter ablation on quality of life. In particular, more research is needed for groups of patients for whom the research is especially lacking, such as women, the elderly, and patients who have other conditions such as heart failure or high blood pressure.

Earlier this year, HHS' Food and Drug Administration approved the first two ablation catheters indicated for use in treating atrial fibrillation, in the United States. However, physicians often use other catheters that have not been approved by the FDA for atrial fibrillation. The FDA also found that there is no conclusive evidence that people whose symptoms are reduced with ablation are less likely to have a stroke. Therefore, the FDA explicitly endorsed existing clinical guidelines that recommend that patients at risk for stroke continue to take preventive blood-thinning medications after radiofrequency catheter ablation.

As a condition of catheter approvals, the FDA mandated that the catheters' manufacturer must conduct two post approval studies (PAS) to collect long term safety data. The mandated studies apply only to FDA-approved catheters, and not to devices used off-label in clinical practice. The first PAS is a post approval registry, which will collect safety (adverse event) data and operator experience inform
'/>"/>

SOURCE Agency for Healthcare Research & Quality
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Sept. 3, 2015 With a population of ... country and therefore also its single largest potential market ... China has led all major world economies in the ... expenditures, and government health expenditures. As an in vitro ... markets of the United States, western European countries, and ...
(Date:9/3/2015)... , Sept. 3,  2015 ... human-made bio-artificial devices, which are implanted or ... natural organs. These include artificial heart, kidney, ... as polymers (polyurethane, polysulfone, and porous polypropylene), ... develop artificial organs. These organs are incorporated ...
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 About ... in dryness of eyes due to deficient tear production ... This syndrome is of two types: aqueous tear deficient ... deficient dry eye, lacrimal glands do not produce enough ... eye. Meibomian glands secrete lipids to slow tear evaporation ...
Breaking Medicine Technology:IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13Global Artificial Organ Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2
(Date:9/4/2015)... (PRWEB) , ... September 05, 2015 , ... Paradise ... from China for an exclusive, one-night exhibition of their work at Paradise Valley Community ... on Friday, September 18, from 6-9 pm. The artists will be on hand to ...
(Date:9/4/2015)... Chicago, IL (PRWEB) , ... September 04, 2015 ... ... 2013 and 2014, Insight Product Development has effectively doubled the size of its ... early stage Midwest medical device and digital health startups to compete for cash ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... The Providence ... to learn more about their fertility and egg freezing. , Date and Time: October ... 6PM to 7PM , This hip and informative event will discuss the basics of ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Health Products Association (CHPA) joint meeting of its Product, Quality and Manufacturers, Dietary ... waste handling rules constantly evolving in the consumer goods industry, it can be ...
(Date:9/4/2015)... Francisco, CA (PRWEB) , ... September 04, 2015 ... ... Amini, announces that CEREC technology is now available at CitiDent. CEREC is a ... machinery. In addition to saving time for patients by eliminating the need for ...
Breaking Medicine News(10 mins):Health News:Paradise Valley Community College Announces Master Ceramic Artists & Exhibit 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:The Providence Fertility Center to Host Fertility Cocktail Hour on October 8, 2015 at Waterman Grille for Women Who Wish to Learn About Their Fertility and Egg Freezing 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2
... getting through the backlog to help claimants with the process ... ... increase in people applying for Social Security disability benefits in 2008 ... according to Allsup , which represents tens of thousands of ...
... and Future Growth Opportunities in Transplant Diagnostics and Genetic ... 30 Gen-Probe Incorporated (Nasdaq: GPRO ), ... human disease, announced today that it has offered to ... Life Sciences, PLC (AIM: TED), a rapidly growing molecular ...
... of Matthew L. MyersPresident, Campaign for Tobacco-Free KidsWASHINGTON, Jan. ... a tremendous victory for children,s health by voting to ... the cigarette tax, to fund reauthorization and expansion of ... This legislation will create a healthier future for millions ...
... Research presented today at the American,Academy of ... correlation,between ,catastrophizing, about pain during the experience of ... parts of the central,nervous system that mediate pain ... this link. Previous studies have looked at ...
... at the American,Academy of Pain Medicine,s 25th Annual Meeting ... public perceptions about their,safety and patient non-compliance in the ... studies at this year,s meeting illuminate the issues faced ... treatments. Two studies,highlight some of the most important ...
... of disease worked, study finds , , THURSDAY, Jan. 29 (HealthDay ... some cases, undo neurological damage in people with multiple sclerosis, ... 21 patients, but a larger, randomized trial is under way ... the first trial for any phase of MS, whether early ...
Cached Medicine News:Health News:Applications for Social Security Disability Reach 2.6 Million 2Health News:Applications for Social Security Disability Reach 2.6 Million 3Health News:Applications for Social Security Disability Reach 2.6 Million 4Health News:Applications for Social Security Disability Reach 2.6 Million 5Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 2Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 3Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 4Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 5Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 6Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 7Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 8Health News:U.S. Senate Acts to Protect Kids, Save Lives by Increasing Federal Tobacco Taxes 2Health News:Negative Emotions About Pain Increase Pro-Inflammatory Response 2Health News:Under-Treatment of Pain Exacerbated by Public Perceptions of Medicines and Safety 2Health News:Under-Treatment of Pain Exacerbated by Public Perceptions of Medicines and Safety 3Health News:Under-Treatment of Pain Exacerbated by Public Perceptions of Medicines and Safety 4Health News:Stem Cell Transplants Help MS Victims 2Health News:Stem Cell Transplants Help MS Victims 3
The CGIL iridectomy contact glass was designed by Riquin, Fankhauser et al. to perform full thickness peripheral laser iridectomies....
The CGVL vitrectomy contact glass was designed by Rol, Fankhauser et al. for photodisruptive YAG laser procedures in the posterior vitreous....
For newly born children 10 mm internal diameter of the cornea part. Designed to work with argon/YAG Lasers....
... The HAAG-STREIT OM 900 Ophthalmometer uses ... the three requirements of Helmholtz: 1. The ... of the distance between the Ophthalmometer and ... are independent of the distance between the ...
Medicine Products: